VeriMomIst valprooyl oligopeptide-33 in der Schwangerschaft sicher?
I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
Related ingredients
Frequently asked questions
- Ist valprooyl oligopeptide-33 in der Schwangerschaft sicher?
- I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
- Ist valprooyl oligopeptide-33 während des Stillens sicher?
- No data located in the referenced authoritative sources for breastfeeding-specific effects of 'valprooyl oligopeptide-33'. In absence of documented systemic absorption or reproductive/breastfeeding data, default hazard/exposure scores remain 0. If the ingredient were to liberate valproic acid systemically, breastfeeding concerns would follow those for valproate, but that linkage is not established here.
- Ist valprooyl oligopeptide-33 sicher für Babyhaut?
- No specific data for infants (0–3 yr) were found. By default there is no evidence of hazard or mechanism for this ingredient. Because infant skin has higher absorption potential for ingredients that are measurably absorbed in adults, I assign a conservative exposure increase of +1 only if the ingredient has any measurable dermal absorption; however, no data confirming adult absorption were located for this specific ingredient.
- Wie bewertet VeriMom valprooyl oligopeptide-33?
- VeriMom bewertet valprooyl oligopeptide-33 mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu valprooyl oligopeptide-33?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu valprooyl oligopeptide-33 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.